Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer

The Afirma Genomic Sequencing Classifier (GSC) is a rule‐out test for malignancy/noninvasive follicular thyroid neoplasms with papillary‐like nuclear features among patients with Bethesda category III/IV nodules, whereas the complimentary Xpression Atlas provides genomic insights from a curated pane...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Syed Z., Siperstein, Allan, Sadow, Peter M., Golding, Allan C., Kennedy, Giulia C., Kloos, Richard T., Ladenson, Paul W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618055/
https://www.ncbi.nlm.nih.gov/pubmed/31017745
http://dx.doi.org/10.1002/cncy.22132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618055/
https://www.ncbi.nlm.nih.gov/pubmed/31017745
http://dx.doi.org/10.1002/cncy.22132

Ejemplares similares